Book a Demo
Platform Overview
Features
Cardiac Amyloidosis Heart Failure Aortic Stenosis Pulmonary Hypertension Strain Stress Echocardiography
Operations
Operational Impact Deployment & Security Integrations Core Lab Solutions EHR Mining Partnerships
Tools
ROI Calculator Reimbursements Peer Comparison Regulatory Status
Library & news
Clinical Evidence Case Studies News
Our Story Careers Media Kit

India Reimbursement for AI Echocardiography

Coding and reimbursement pathways in India for echocardiography across CGHS (government employees), PM-JAY (Ayushman Bharat), state schemes, organised-sector ESI, and the private / self-pay market.

See all markets

Reimbursement Landscape in India

Echocardiography in India is reimbursed through a mosaic of public schemes (CGHS, PM-JAY, state plans, ESI) and a large private / commercial insurance sector. CGHS publishes a Revised Schedule of Charges for empanelled hospitals; PM-JAY uses Health Benefit Packages with bundled per-case rates; private insurers and self-pay rates dominate metro-city volume.

CGHS

The Central Government Health Scheme covers serving and retired Central Government employees and their dependants. CGHS publishes a Revised Schedule of Charges that empanelled hospitals follow for procedures including TTE and stress echo.

PM-JAY / Ayushman Bharat

Pradhan Mantri Jan Arogya Yojana (Ayushman Bharat) is the world's largest health-insurance scheme by beneficiary count. Health Benefit Packages (HBPs) bundle procedures by case; echocardiography sits within cardiology HBPs.

Private & Commercial

Private insurers (Star Health, HDFC ERGO, Niva Bupa, ICICI Lombard, etc.) and self-pay represent the majority of urban tertiary-care volume. Hospital MRP for echo studies typically runs INR 2,500–5,000 outside of any pre-negotiated insurer rates.

Relevant Coding

India's schemes use scheme-specific procedure descriptors rather than a single national code system. CGHS RSC and PM-JAY HBP codes are illustrative.

CGHS
CGHS 2D Echo

TTE under CGHS

2D transthoracic echocardiography under the CGHS Revised Schedule of Charges for empanelled hospitals (revised w.e.f. 19 June 2023).

CGHS rate: <strong>INR 1,255</strong> at Non-NABH hospitals; <strong>INR 1,475</strong> at NABH-accredited hospitals. Empanelled hospitals accept the CGHS rate as full payment for CGHS beneficiaries. Use of AI-assisted reporting is supported within the same code.

Scheme CGHS (Revised Schedule of Charges)
Non-NABH rate INR 1,255
NABH rate INR 1,475
Source cghs.gov.in
CGHS
CGHS Stress Echo

Stress Echocardiography (CGHS)

Stress echocardiography under the CGHS Revised Schedule of Charges. Separate rates for exercise stress and pharmacologic (dobutamine) stress.

CGHS rates: exercise stress echo <strong>INR 2,040</strong> (Non-NABH) / <strong>INR 2,400</strong> (NABH); pharmacologic / dobutamine stress echo <strong>INR 2,550</strong> (Non-NABH) / <strong>INR 3,000</strong> (NABH). AI-assisted strain and EF support peak-stress interpretation across multi-physician teams.

Scheme CGHS
Exercise stress (NABH) INR 2,400 (1,840 Non-NABH)
Pharmacologic stress (NABH) INR 3,000 (2,550 Non-NABH)
Source cghs.gov.in
PM-JAY
HBP (bundled)

TTE within Health Benefit Package

Echocardiography under PM-JAY / Ayushman Bharat is not billed as a standalone line item; it is bundled within the relevant cardiology Health Benefit Package (HBP) case rate published by the National Health Authority.

PM-JAY HBP 2.2 bundles admission, diagnostics, treatment, and follow-up into an all-inclusive case rate that covers the full cardiology admission. Echo as a standalone diagnostic is not a separately billable HBP line; for a diagnostic-only outpatient echo workflow on a PM-JAY beneficiary, providers typically route to the state scheme or charge at the empanelled CGHS / state rate.

Scheme PM-JAY (Ayushman Bharat)
Echo billing Bundled within cardiology HBP
Reference HBP 2.2 (NHA, latest)
Source nha.gov.in / pmjay.gov.in

CGHS rates shown are the central Revised Schedule of Charges effective from 19 June 2023, with the latest update circulated in July 2024 (Non-NABH rates are 15% lower than NABH-accredited hospital rates by design). PM-JAY HBP case rates change with each HBP edition (currently HBP 2.2). Private hospital MRP and commercial insurer rates vary widely. State health schemes (Tamil Nadu CMCHIS, Karnataka Yeshasvini, Maharashtra MJPJAY, Rajasthan RGSHS, etc.) publish their own package rates. Verify with the relevant scheme and empanelled hospital MoU.

Model the impact on your service

Enter your annual echo volume mix across CGHS, PM-JAY, private insurance, and self-pay to estimate net new capacity.

Reimbursement by Care Setting

India's reimbursement mosaic produces different per-study revenue per setting; volume and case mix vary materially between tier-1 metros, tier-2 cities, and rural / district hospitals.

Government Schemes

CGHS, PM-JAY, ESI, and state plans cover government employees and economically vulnerable groups. Per-study rates are fixed by the scheme.

Payment route CGHS RSC / PM-JAY HBP / ESI / state
Components Bundled case rate or per-procedure
Volume Largest pool by patient count

AI-assisted reporting supports throughput within scheme-fixed rates and helps empanelled hospitals manage case volume.

Commercial Insurance

Private health insurers cover middle-class urban beneficiaries. Pre-authorisation and rate cards apply at network hospitals.

Payment route Insurer rate card via network MoU
Pricing Varies; typically above CGHS rate
Authorisation TPA-managed cashless or reimbursement

Volume is concentrated in tier-1 / tier-2 metros and at corporate hospital groups (Apollo, Fortis, Manipal, Max, Medanta, etc.).

Self-Pay

Out-of-pocket payments still represent a large share of healthcare spend in India. Patients pay the hospital MRP directly.

Payment route Patient direct to hospital
Pricing Hospital MRP, varies widely by city / tier

Indian Procurement & Regulatory Context

AI echocardiography software in Indian hospitals is assessed against CDSCO regulation, DPDPA data-protection law, and IT-Health certification frameworks like NABH and NABL.

CDSCO Registration

Software classified as a medical device requires CDSCO registration under the Medical Device Rules 2017. Us2.ai is CDSCO-registered.

DPDPA Data Protection

The Digital Personal Data Protection Act (DPDPA) 2023 is the new federal framework for data handling, with subordinate rules in progress. Localisation requirements apply for certain categories; APAC-region cloud hosting and on-premise deployment are supported.

NABH & NABL

Hospital accreditation (NABH) and laboratory accreditation (NABL) frameworks are commonly required for empanelment with CGHS, PM-JAY, and major commercial insurers. AI-assisted diagnostic tools fit within the NABH digital health / clinical decision-support tracks.

Frequently Asked Questions

Common questions about echocardiography coding and reimbursement in India.

What is the CGHS Revised Schedule of Charges?
The CGHS RSC is the central rate card published by the Ministry of Health and Family Welfare for procedures performed at CGHS-empanelled hospitals. The cardiology echo rates were revised w.e.f. 19 June 2023 and last circulated in July 2024: 2D Echo INR 1,475 (NABH) / INR 1,255 (Non-NABH); exercise stress echo INR 2,400 (NABH) / INR 2,040 (Non-NABH); pharmacologic / dobutamine stress echo INR 3,000 (NABH) / INR 2,550 (Non-NABH). Non-NABH hospitals receive 15% less than NABH-accredited hospitals by design. Empanelled hospitals accept the CGHS rate as full payment for CGHS beneficiaries.
How do PM-JAY Health Benefit Packages work?
PM-JAY (Ayushman Bharat) bundles procedures into Health Benefit Packages (HBPs) with a fixed all-inclusive case rate. The case rate covers admission, diagnostics, treatment, and follow-up within a defined window; individual components like echocardiography are not separately billed within an HBP.
Is Us2.ai CDSCO-registered?
Yes. Us2.ai is CDSCO-registered under the Medical Device Rules 2017. See the Regulatory Status page for full clearance and certificate detail.
What about state schemes?
Major states operate their own schemes: Tamil Nadu CMCHIS, Karnataka Yeshasvini, Maharashtra MJPJAY, Rajasthan RGSHS, Andhra Pradesh Aarogyasri, etc. Many converge with PM-JAY for joint coverage. Each publishes its own package rates and empanelment criteria.
Are there India-specific codes for AI echocardiography?
As of the current CGHS RSC, PM-JAY HBPs, and ESI Schedule of Charges, there is no India-specific code that corresponds to the US Category III CPT code for AI-assisted heart failure detection. AI-assisted reporting today sits within the existing echo descriptors.
How does DPDPA affect AI deployment in cardiology?
The Digital Personal Data Protection Act 2023 governs personal data processing in India; subordinate rules are progressing. Sensitive personal data (including health data) is subject to additional safeguards. Us2.ai supports APAC-region cloud hosting and on-premise deployment.
What does empanelment require?
Empanelment with CGHS, PM-JAY, ESI, or state schemes requires meeting infrastructure, staffing, and accreditation criteria (typically NABH for hospitals, NABL for diagnostics). MoUs include rate acceptance and reporting commitments.
Where can I get India-specific reimbursement guidance?
Our team can provide detail tailored to corporate hospital groups, government-empanelled hospitals, and standalone diagnostic centres with current scheme-rate context, CDSCO documentation, and clinical evidence. Contact us for India-specific guidance.

Important Information

Information is provided for general informational purposes only and is not a guarantee of coverage or reimbursement. CGHS RSC rates, PM-JAY HBPs, ESI schedules, state-scheme packages, and commercial insurer rate cards are subject to change. Providers should verify against the relevant scheme. CGHS is administered by MoHFW; PM-JAY by NHA.

Questions about India Reimbursement?

Our team can support business cases for corporate hospital groups, government-empanelled tertiary centres, and standalone diagnostic chains with current scheme-rate context, CDSCO documentation, and clinical evidence.

Contact Us